RIDGEFIELD, Conn. and NEW YORK, May 31, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.

SAN FRANCISCO, May 22, 2012 /PRNewswire/ -- Boehringer Ingelheim announced today results from a Phase II study evaluating the investigational compound tiotropium delivered once-daily via the

SAN FRANCISCO, May 21, 2012 /PRNewswire/ -- Data from a Phase II trial of olodaterol presented today at the 2012 Annual International Conference of the American Thoracic Society (ATS 2012)

RIDGEFIELD, Conn., May 15, 2012 /PRNewswire/ -- According to a new national survey sponsored by the makers of Dulcolax®, constipation ranks as one of the top women's health issues that women

RIDGEFIELD, Conn., May 8, 2012 /PRNewswire/ -- Boehringer Ingelheim will present the latest data from its respiratory research pipeline at the Annual International Conference of the American